« India-Nepal Friendship Eye Camp in Various Districts of Nepal
Rabbis Support Missouri Stem Cell Research and Cures Initiative »

Phase-II Clinical Trial of Drug Evizon for Wet Age-Related Macular Degeneration

Biopharmaceutical company Genaera Corporation has commenced a multi-center phase II clinical trial to explore the efficacy and safety of higher doses of its investigational drug Evizon for the treatment of the eye disease, wet age-related macular degeneration. Read the full article here.

Filed under Eye Treatment, Macular Degeneration

You may also like to read

This entry was posted on Wednesday, June 28th, 2006 at 8:23 am and is filed under Eye Treatment, Macular Degeneration. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply



Please enter the code shown below ( to verify that you are human ) before you click Submit Comment.